I am a structural biologist. This is one of the handful of topics that overlaps with my field here. I'm very excited to play with this, although it might eventually put me out of a job.
Here's where I think we need to be going: You go to a doctor's office, sick. 1) They take a blood sample. 2) They find the malignant bacteria and DNA sequence it. 3) If it's a known strain, they know what antibiotics to use on it. 4) If not, they solve protein folding on the genes. 5) From that, they see which existing antibiotics would kill it. 6) If none will, then given the proteins, they have to derive a new anti…
DNA sequencing is still slow and very expensive. On the scales you're talking about it's just not worth it.
I think I agree at a high-level that there is a huge reservoir of demand for this technology. But it's also possible that solving protein folding and similar research will simply cease to be a bottleneck for that demand, and people will be out of jobs.